SiMPLInext SA

Tools to foster industrial applicability and acceptance of in vitro

General Information
Company Name
SiMPLInext SA
Founded Year
2016
Location (Offices)
Switzerland +1
Founders / Decision Makers
Number of Employees
1
Industries
Health Care
Funding Stage
Grant
Social Media

SiMPLInext SA - Company Profile

SiMPLInext SA is a Swiss startup that focuses on advanced cell culture, with the goal of fostering industrial applicability and acceptance of in vitro testing. Their slogan "Tools to foster industrial applicability and acceptance of in vitro" encapsulates their mission perfectly. This innovative company addresses the unreliability of current conventional tissue models, offering a drop-in replacement cell culture insert that significantly enhances the reliability, relevance, reproducibility, scope, and quality of data acquired through in vitro models of biological barriers. SiMPLInext's inserts allow for better cultivation of biological barriers, quality control of their function in situ, and the collection of in situ measured data. This breakthrough enables toxicologists and drug designers to gain a deeper understanding of their biological barriers without disrupting existing processes or protocols. Founded in 2016, SiMPLInext SA operates in a unique niche within the biotech sector, focusing on improving the effectiveness and practicality of in vitro testing. Although details about their last investment and investors are currently unavailable, the potential of SiMPLInext to disrupt and advance the field of advanced cell culture is noteworthy. With its innovative approach and potential to revolutionize in vitro testing, SiMPLInext SA is a startup worth watching in the biotech industry.

Taxonomy: Cell culture, In vitro testing, Biological barriers, Toxicology, Drug design, Quality control, Reproducibility, Industrial applicability, Acceptance, Advanced technology, Biomedical research, Tissue models, Innovation, Research and development

Funding Rounds & Investors of SiMPLInext SA (2)

View All
Funding Stage Amount No. Investors Investors Date
Grant Fr.20.00K 1 16 Sep 2015
Grant Fr.10.00K 1 26 Mar 2015

Latest News of SiMPLInext SA

View All

No recent news or press coverage available for SiMPLInext SA.

Similar Companies to SiMPLInext SA

View All
3D Genomics  - Similar company to SiMPLInext SA
3D Genomics We work with you to design the study, build the best cell models and develop informative data analysis workflows.
Bi/ond - Similar company to SiMPLInext SA
Bi/ond Accurate disease models and more personalized medicine, by recreating human physiology & pathology in a 3D model
FiberCell Systems Inc.  - Similar company to SiMPLInext SA
FiberCell Systems Inc. FiberCell Systems is the leading supplier of hollow fiber bioreactors to the biomedical research community.
PFI - Similar company to SiMPLInext SA
PFI Organoid Discovery Engine - The Future of 3D Cell-based Assays
Scale Biosciences - Similar company to SiMPLInext SA
Scale Biosciences Boldly go where your single cell research takes you.